Literature DB >> 23467078

Long-term physico-chemical stability of diluted trastuzumab.

Muriel Paul1, Victoire Vieillard, Ricardo Da Silva Lemos, Laurence Escalup, Alain Astier.   

Abstract

Using several complementary analytical methods, we demonstrated that the monoclonal antibody Trastuzumab (Tz), diluted in 0.9% sodium chloride can be stored in polyolefin infusion bags at 4°C or room temperature up to 6 months with no evidence of chemical or physical instability. No aggregation of Tz was observed and its three dimensional structure remains unaltered. Thus, the practical use of diluted Tz can be safely extended to optimize the workload of centralized preparation units and to minimize costs.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23467078     DOI: 10.1016/j.ijpharm.2013.02.039

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  MAbDelivery: Administration routes for antibody therapy Third LabEx MAbImprove industrial workshop, July 2, 2015 Tours, France.

Authors:  Elsa Bodier-Montagutelli; Renaud Respaud; Hervé Watier; Audrey Guillon-Munos
Journal:  MAbs       Date:  2017-02-28       Impact factor: 5.857

2.  The impact of logarithmic dose banding of anticancer drugs on pharmacy compounding efficiency at Ghent University Hospital.

Authors:  Barbara Claus; Kaat De Pourcq; Nele Clottens; Vibeke Kruse; Paul Gemmel; Johan Vandenbroucke
Journal:  Eur J Hosp Pharm       Date:  2017-03-04

3.  Stability of erythropoietin repackaging in polypropylene syringes for clinical use.

Authors:  Angela Marsili; Giorgia Puorro; Chiara Pane; Anna de Rosa; Giovanni Defazio; Carlo Casali; Antonio Cittadini; Giuseppe de Michele; Brunello Ettore Florio; Alessandro Filla; Francesco Saccà
Journal:  Saudi Pharm J       Date:  2016-01-14       Impact factor: 4.330

4.  Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties.

Authors:  Jihoon Yun; Jihyun Kim; Jihyun Chung; Su-Jeong Hwang; Su Jin Park
Journal:  Adv Ther       Date:  2019-05-17       Impact factor: 3.845

5.  Study of the Stability of Sandoz Rituximab Biosimilar Rixathon®/Riximyo® When Subjected for up to 21 Days to Ambient Storage.

Authors:  Roman Borišek; André Mischo; Ida Šmid
Journal:  Drugs R D       Date:  2022-08-07

6.  Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial.

Authors:  Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel
Journal:  Pharmaceuticals (Basel)       Date:  2015-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.